A clinical trial of enflurane with paediatric patients is reported and confirms that it is a satisfactory inhalational anaesthetic agent without serious adverse effects. * Registrar.
INTRODUCTION
Numerous fluorinated compounds have been synthesized and tested in an effort to find safe and useful anaesthetic agents. The first fluorinated anaesthetic to progress through animal and clinical trials was fluoroxene (Krantz et al. 1953) . This was soon superseded by the introduction of halothane in 1956 and with methoxyflurane in 1961. These agents have had a prominent place in anaesthesia and halothane in particular has been widely used. Halothane has been incriminated as a cause of postoperative jaundice although a critical review of the cases has cast doubt on this (Simpson, Strunin and Walton 1973) . Methoxyflurane has been shown to cause high output renal failure when used in high concentrations for long periods (Mazze and Cousins 1973) . Of the recently developed agents, enflurane has been released for clinical use in Australia. Its physico-chemical properties are summarized in Table 1 where it is compared with halothane and methoxyflurane. Like methoxyflurane it is a halogenated ether but its physical properties are more closely related to those of halothane and it behaves more like halothane in clinical practice.
The purpose of this study has been twofold: l. To conduct biochemical and haematological screening tests before and after the administration of enflurane. 2. To make clinical observations of its effects in children when administered by commonly used methods.
METHODS

(a) Clinical
One hundred patients were fasted for at least six hours preoperatively. They were premedicated with papaveretum (0·4 mg/kg) and scopolamine (0'008 mg/kg) which was given 1 to li hours preoperatively. Most of the patients were induced with thiopentone (5 mg/ kg); some were induced with nitrous oxide, oxygen and enflurane. Enflurane was used with controlled ventilation as a supplement to non depolarizing relaxant anaesthesia in 14 patients. In the remainder it was administered with the patients breathing spontaneously, either by mask or, in 50 children, following intubation facilitated by suxamethonium. Enflurane was vaporized in the majority of cases in a Cyprane vaporizer of the Fluotec Mark II type re-calibrated for enflurane and placed outside the circle. It was administered in a closed circuit to 40 patients using either a Goldman vaporizer in circuit or a Cole vaporizer (Cole 1961 ) out of circuit. The circle absorption system was used for children over 25 kilograms while a J ackson Rees modified A yres T piece was employed for the smaller children.
An intravenous infusion of five per cent Dextrose and 0·22 per cent saline was given to 38 patients, and whole blood was administered to one patient.
Systolic blood pressure, heart rate and respiratory rate were recorded preoperatively and at five minute intervals intraoperatively. E.C.G. was monitored in 20 patients. The vaporizer concentration was also noted regularly throughout anaesthesia.
Postoperative vomiting was recorded by the nursing staff for the first 18 hours after the anaesthetic. Records were also kept of the occurrence of incidents such as laryngeal spasm, respiratory depression, muscle stiffness or movements and secretions. Postoperative temperature was measured on arrival in the recovery room in 33 patients and it was also noted whether or not they shivered.
(b) Laboratory
Pre and postoperative blood samples were taken:
1. Immediately preoperatively 111 the induction room, 2. In the recovery room one hour after the conclusion of the procedure, and 3. lS-2J hours postoperatively in the ward. Measurements were made of haemoglobin, white cell count, blood sugar, serum glutamic oxaloacetic transaminase (SGOT), blood urea and serum creatinine.
Early morning urine specimens were obtained on the day of operation and the day following operation and these were analysed for pH, specific gravity, protein, sugar,' ketones and blood.
RESULTS
The haematological and biochemical results for 100 patients studied are summarized in Table 2 . No abnormalities were detected in the urine examinations. The mean heart rate and blood pressure recordings were compared and changes are summarized in Table 3 . The pulse and blood pressure, when reduced, tended to rise towards preoperative levels with surgical stimulation or lightening of anaesthesia. 'Maximum depression of blood pressure occurred during induction and with deeper levels of anaesthesia. No arrhythmias were detected clinically or in 20 patients where the E.C.G. was monitored. When an inhalation induction with nitrous oxide~enfiurane was employed, most patients experienced moderate excitation prior to unconsciousness which usually occurred within three minutes when enfiurane concentrations of 2-3 per cent were used. The maintenance concentration averaged between 1·25 and 1·5 per cent.
Both respiratory rate and tidal volume were reduced and this became more marked with deeper anaesthesia. The deep sigh, reported by Dobkin et al. (1968) and Lebowitz (1970) , during light anaesthesia was not observed. A notable feature was the ease with which respiration could be controlled, and the difficulty which was sometimes encountered in re-establishing spontaneous ventilation following the use of suxamethonium for intubation. Enfiurane was well tolerated by the respiratory tract and coughing, bucking or production of secretions were rare.
Post extubation laryngeal spasm occurred in twelve patients but the incidence decreased as experience was gained with the drug.
The incidence of postoperative vomiting during the first 18 hours post operatively in 100 children was 35 per cent. Four patients vomited during emergence.
The results of postoperative temperatures in relation to shivering are summarized in Table 4 . Seven out of 33 patients shivered postoperatively.
Muscle tone was reduced sufficiently to provide good operating conditions for the orthopaedic procedures. Tonic and clonic movements reported by others (Dobkin et al. 1969) were not seen.
Observations on the pupil size and position gave a useful indication of depth being central and constricted at deeper planes of anaesthesia, divergent and of variable diameter during lighter planes, and central and relatively dilated when awake.
Blood loss did not appear more than usual for comparable procedures but it was noted that there was an increased tendency to oozing where enfiurane was used with spontaneous ventilation for micro-surgical procedures on the ear.
DISCUSSION
The biochemical and haematological tests were aimed to detect any marked deviation from preoperative levels which might indicate toxic haematological, hepatic or renal effects which would require further investigation. The only deviations from the normal laboratory limits were the blood glucose and white cell counts one hour post operatively. Blood glucose does rise following the administration of several inhalation anaesthetic agents, particularly those releasing catecholamines such as ether and cyclopropane (Greene 1963) . The blood glucose levels in all patients including those who had intravenous dextrose infusions were normal in the 18-24 hour postoperative sample.
The elevation of white cell count is common following anaesthesia and surgery. There is no indication from the laboratory tests conducted that enfiurane caused any major adverse effects.
Clinically, enflurane caused cardiovascular depression with a fall in blood pressure and respiratory depression more marked with deeper planes of anaesthesia. Both rate and depth of respiration were decreased and this contrasts with some other anaesthetic agents which tend to increase respiratory rate with decreasing tidal volume.
The study of postoperative temperature and shivering was inconclusive, but the incidence of shivering seemed to decrease when more care was taken to prevent intraoperative heat loss.
The incidence of postoperative vomiting (35 per cent) is relatively high, but the incidence in children following other inhalational anaesthetics often approaches this level when they are observed for 18 to 24 hours postoperatively (Brown 1975) .
Important clinical points were the tendency to extubation laryngeal spasm, the ease with which ventilation can be controlled and the difficulty in re-establishing respiration following the use of suxamethonium.
Enflurane has been employed satisfactorily in this trial using a variety of techniques commonly employed in paediatric anaesthesia.
The general assessment was that it is another satisfactory inhalation agent, but does not appear to have distinct advantages over halothane in paediatric anaesthesia.
